AIxCrypto Holdings, Inc. is a clinical-stage biopharmaceutical company committed to discovering and developing innovative treatments for both adult and pediatric oncology. Its ...
AIxCrypto Holdings, Inc. (NASDAQ: AIXC) is headquartered in Carlsbad, California, and was founded in 1996. The company’s public description indicates a dual narrative: (1) a clinical-stage biopharmaceutical focus on discovering and developing treatments for adult and pediatric oncology, and (2) a technology ecosystem direction that integrates artificial intelligence with blockchain ...AIxCrypto Holdings, Inc. (NASDAQ: AIXC) is headquartered in Carlsbad, California, and was founded in 1996. The company’s public description indicates a dual narrative: (1) a clinical-stage biopharmaceutical focus on discovering and developing treatments for adult and pediatric oncology, and (2) a technology ecosystem direction that integrates artificial intelligence with blockchain while aiming to bridge Web2 and Web3.
From the biopharmaceutical perspective, the company highlights QN-302, a small molecule described as a G-quadruplex (G4)-selective transcription inhibitor. QN-302 is characterized as progressing through Phase I clinical trials for pancreatic cancer and other solid tumors. In addition, the company references Pan-RAS as a preclinical-stage program targeting advanced solid tumors. These program stages suggest an R&D-heavy operating model typical of early-stage oncology development companies, where external financing, clinical milestones, and continued investment in drug discovery are key to progress.
From the technology and ecosystem perspective, supplied notes describe AIxCrypto as building an AI + blockchain ecosystem and developing initiatives intended to connect traditional internet (Web2) users with decentralized systems (Web3). While specific technical product details are not provided in the excerpt, the company’s positioning implies an emphasis on platform strategy, community/participant tooling, and AI-enabled experiences or infrastructure layered with blockchain components.
In terms of scale, the provided data lists approximately 10 full-time employees (and also references a “51–200 employees” range in other summaries). Given the direct “Full Time Employees: 10” field in the provided dataset, the employee size bucket is treated as the closest match: 0–100 employees. The combination of a small team and multiple development tracks (clinical/preclinical drug programs plus technology ecosystem initiatives) typically indicates a lean corporate structure with reliance on scientific collaborators, contract research organizations, and partners for execution.
Cost and financial profile information in the dataset (e.g., operating/return metrics and negative cash-flow indicators in a TTM snapshot) is consistent with early-stage investment cycles where revenue may be limited and cash burn can occur as clinical and platform efforts proceed. Key leadership is identified as Jiawei Wang (CEO) in the provided data; additional leadership references exist but vary across sources, so Jiawei Wang is used as the CEO name where explicitly stated.
Overall, AIxCrypto presents itself as a repositioned public company (rebranded from Qualigen Therapeutics, Inc. to AIxCrypto Holdings, Inc. in November 2025 per the description) aiming to pursue oncology therapeutics alongside an AI+blockchain ecosystem strategy. Investors and stakeholders would typically look for updates on clinical progress for QN-302, advancement of preclinical Pan-RAS, and tangible milestones demonstrating the commercial traction of its AI/Web3 ecosystem initiatives.
YoYYoY means Year-over-Year. It compares the latest annual value with the previous annual value to show long-term trend strength.
QoQQoQ means Quarter-over-Quarter. It compares the latest quarter with the immediately previous quarter to show short-term momentum changes.
RevenueThe total money that came through the front door from selling things, before paying a single bill. Think of it as the grand total of every credit card swipe from customers. (YoY compares this year to last year's performance, while QoQ compares the current three months to the previous three).
$0
—
—
Net IncomeThe absolute bottom line. If the company paid every single supplier, employee, banker, and tax collector, this is the actual money left in their pocket at the end of the day.
$-17.0M
-171.1%
+31.1%
Gross MarginThe basic markup. If they sell a $100 pair of sneakers, this percentage tells you how much of that price tag is profit right after paying for the rubber and shoelaces, but before paying for things like store rent or TV commercials.
—
—
—
Operating MarginThe 'day job' efficiency score. Out of every dollar a customer spends, this shows how many cents the company keeps after making the product AND paying for all the everyday corporate overhead (like salaries, marketing, and keeping the lights on).
—
—
—
Net MarginThe final take-home percentage. When you strip away every conceivable cost, tax, and interest payment, this is the exact number of cents the company truly gets to keep from every dollar in sales.
—
—
—
Free Cash FlowThe holy grail of corporate cash. It's the spendable, physical money left over after the business pays for its daily operations AND buys the big, expensive upgrades (like new factories or servers) it needs to survive. This is the 'free' money they can use to pay dividends or buy back stock.
$-23.5M
-272.1%
+23.4%
FCF MarginThe ultimate cash conversion rate. It shows how good the company is at turning regular sales directly into cold, hard, spendable cash. A high percentage means the business is an absolute cash-printing machine.
—
—
—
Debt / EquityThe financial risk gauge. It compares how much of the company's empire was built using borrowed money (loans) versus the owners' own money (shareholders). A high number means they are heavily leveraged and playing a riskier game; a low number means they are playing it safe.
0.5%
—
—
Current RatioThe 12-month survival check. It simply compares the cash they have right now (plus things they can quickly turn into cash) against the immediate bills they absolutely must pay this year. A score above 1 means they have enough in the wallet to cover the upcoming bills without panicking.
9.30x
+298.4%
-68.2%
Total AssetsThe absolute size of the company's empire. It bundles together absolutely everything of value they own—from the cash in the register and the inventory in the warehouse, to the software patents in the vault and the factories on the ground.
Operator: Greetings. Welcome to AIxCrypto Holdings, Inc. Second Quarter 2026 Earnings Call. [Operator Instructions] Please note, this conference is being recorded. I will now turn the conference over to Andrew Grossman, Head of Legal for AIXC. Thank you. You may begin.
Andrew Grossman: Good afternoon. My name is Andrew Grossman, and I'd like to welcome you to the AIxCrypto Holdings Second Quarter 2026 Earnings Conference Call. [Operator Instructions] As a reminder, a replay of this call will be available on the company's Investor Relations website. On today's call are Jerry Wang, the company's CEO; and Jay Sheng, the company's President and CFO. Mr. Wang will cover the company's strategy, business operations and capital matters, and Mr. Sheng will cover the financial results and outlook. Before we begin, please note that today's discussion contains forward-looking statements within the meaning of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. These statements include, among other things, statements regarding the company's strategy, product plans and time lines, targeted milestones, expected expenses, liquidity and capital resources and anticipated business developments. Forward-looking statements are based on management's current expectations and assumptions and are subject to risks and uncertainties that could cause actual results to differ materially, including the risk factors described in the company's annual report on Form 10-K and its quarterly reports on Form 10-Q filed with the SEC. The company's financial statements have been prepared on a going concern basis, and the related disclosures in the Form 10-Q describe conditions that raise substantial doubt about the company's ability to continue as a going concern. The company undertakes no obligation to update forward-looking statements, except as required by law. All figures discussed today are unaudited. I would now like to turn the call over to Jerry Wang, AIXC's CEO.
Jiawei Wang: Thank you, Andrew, and thank you to everyone joining us. The second quarter and the weeks that followed marked an important transition for AIXC from strategic planning toward focused execution. We designated RoboShare as the company's top priority for the second half of 2026, and preparations for its Los Angeles launch are now underway. Our focus is on transitioning the strategy introduced during the quarter into tangible commercial progress. We have established a clear go-to-market plan, defined measurable operating priorities and aligned our resources around the initiatives we believe offer the strongest path towards commercialization. In parallel, evaluating strategic opportunities that may strengthen the business remains a standing part of our long-term planning. I will cover our strategy and business together, followed by capital, and Jay will close with the financials. Q2 2026 operational highlights. First, RoboShare marketplace launch and Los Angeles pilot. Our core …